Sept. 14, 2018
Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough drug to treat acute myeloid leukemia (AML), one of the most aggressive cancers.
Professor Yinon Ben-Neriah, who heads the research team, said the new drug “targets many leukemia proteins at once and destroys all of the oncogenes [that have the potential to cause cancer], and activates the tumor suppressor P53 gene.”
Researchers are trying to expand the drug’s use to other cancers, including lymphoma, multiple myeloma, melanoma and colorectal cancer.
A revolutionary Israeli device is enabling quadriplegics to navigate all kinds of indoor and outdoor terrain either seated or upright while maintaining perfect equilibrium.
Dr. Amit Goffer – himself a quadriplegic who invented the ReWalk bionic exoskeleton – has developed a specialized wheelchair at UPnRIDE Robotics, a next-generation mobility enhancer.
HemoScreen – developed by PixCell Medical Technologies – “performs the world’s most common blood test, which is the complete blood count (CBC), within five minutes,” said CEO Dr. Avishay Bransky.
“When you go into the physician’s office he’ll be able to diagnose and treat you in a single visit.”
The HemoScreen unit, roughly the size of a lunchbox, can also detect allergies, anemia and even cancer, among other afflictions.